Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026)
Becton Dickinson (BDX) reported Income from Continuing Operations of 37000000.0 for Q1 2026, down 123.42% year-over-year from 158000000.0 in Q1 2025, and down 109.69% quarter-over-quarter from 382000000.0 in Q4 2025.
Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Income from Continuing Operations data on file, last reported at 37000000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 37000000.0, down 123.42% year-over-year; the trailing twelve-month figure through Mar 2026 was 1412000000.0 (up 4.75% YoY), and the FY2025 annual result was 1678000000.0, down 1.58% from the prior year.
- Income from Continuing Operations slipped to 37000000.0 in Q1 2026 per BDX's latest filing, from 382000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 574000000.0 in Q2 2025 and troughed at 37000000.0 in Q1 2026.
- A 5-year average of 363294117.65 and a median of 390000000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2026: Income from Continuing Operations surged 161.44% in 2024, then tumbled 123.42% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 509000000.0 in 2022, then plunged by 44.6% to 282000000.0 in 2023, then climbed by 7.45% to 303000000.0 in 2024, then increased by 26.07% to 382000000.0 in 2025, then sank by 109.69% to 37000000.0 in 2026.
- Business Quant data shows BDX's Income from Continuing Operations at 37000000.0 in Q1 2026, 382000000.0 in Q4 2025, and 493000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 72.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 493.00 Mn |
| Jun 30, 2025 | 574.00 Mn |
| Mar 31, 2025 | 158.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 487.00 Mn |
| Mar 31, 2024 | 537.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 153.00 Mn |
| Jun 30, 2023 | 407.00 Mn |
| Mar 31, 2023 | 461.00 Mn |
| Dec 31, 2022 | 509.00 Mn |
| Sep 30, 2022 | 287.00 Mn |
| Jun 30, 2022 | 390.00 Mn |
| Mar 31, 2022 | 390.00 Mn |
| Dec 31, 2021 | 568.00 Mn |
| Sep 30, 2021 | 155.00 Mn |
| Jun 30, 2021 | 406.00 Mn |